Abstract
We propose a compartmental disease transmission model with an asymptomatic (or subclinical) infective class to study the role of asymptomatic infection in the transmission dynamics of infectious diseases with asymptomatic infectives, e.g., influenza. Analytical results are obtained using the respective ratios of susceptible, exposed (incubating), and asymptomatic classes to the clinical symptomatic infective class. Conditions are given for bistability of equilibria to occur, where trajectories with distinct initial values could result in either a major outbreak where the disease spreads to the whole population or a lesser outbreak where some members of the population remain uninfected. This dynamic behavior did not arise in a SARS model without asymptomatic infective class studied by Hsu and Hsieh (SIAM J. Appl. Math. 66(2), 627–647, 2006). Hence, this illustrates that depending on the initial states, control of a disease outbreak with asymptomatic infections may involve more than simply reducing the reproduction number. Moreover, the presence of asymptomatic infections could result in either a positive or negative impact on the outbreak, depending on different sets of conditions on the parameters, as illustrated with numerical simulations. Biological interpretations of the analytical and numerical results are also given.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arino, J., Brauer, F., van den Driessche, P., Watmough, J., Wu, J., 2006. Simple models for containment of a pandemic. J. R. Soc. Interface 3, 453–457.
Bell, D.M., World Health Organization Writing Group, 2006. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg. Infect. Dis. 12(1), 81–87.
Chan, P.K., 2002. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin. Infect. Dis. 34(Suppl. 2), S58–S64.
Coppell, W.A., 1965. Stability and Asymptotic Behavior of Solutions of Differential Equations. Heath, Boston.
Diekmann, O., Heesterbeek, J.A.P., 2000. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation. Wiley Series in Mathematical and Computational Biology. Wiley, New York.
Eccles, R., 2005. Asymptomatic spread of flu is not proved. Br. Med. J. 331(7525), 1145.
Ferguson, N.M., Cummings, D.A., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., Burke, D.S., 2005. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437, 209–214.
Ferguson, N.M., Cummings, D.A., Fraser, C., Cajka, J.C., Cooley, P.C., Burke, D.S., 2006. Strategies for mitigating an influenza pandemic. Proc. Natl. Acad. Sci. U.S.A. 103(15), 5935–5940.
Germann, T.C., Kadau, K., Longini Jr., I.M., Macken, C.A., 2006. Mitigation strategies for pandemic influenza in the United States. Proc. Natl. Acad. Sci. U.S.A. 103, 5935–5940.
Graat, J.M., Schouten, E.G., Heijnen, M.L., Kok, F.J., Pallast, E.G., de Greeff, S.C., Dorigo-Zetsma, J.W., 2003. A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. J. Clin. Epidemiol. 56(12), 1218–1223.
Hsieh, Y.-H., van den Driessche, P., Wang, L., 2007. A multi-patch model for spatial spread of disease: impact of travel between patches. Bull. Math. Biol. 69(4), 1355–1375.
Hsu, S.B., Hsieh, Y.-H., 2006. Modeling intervention measures and public response during SARS outbreak. SIAM J. Appl. Math. 66(2), 627–647.
Longini, I.M., Halloran, M.E., Nizam, A., Yang, Y., 2004. Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 159, 623–633.
Longini, I.M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D.A., et al., 2005. Containing pandemic influenza at the source. Science 309, 1083–1087.
Monto, A.S., Gunn, R.A., Bandyk, M.G., King, C.L., 1979. Prevention of Russian influenza by amantadine. J. Am. Med. Assoc. 241, 1003–1007.
Nafta, I., Turcanu, A.G., Braun, I., Companetz, W., Simionescu, A., Birt, E., Florea, V., 1970. Administration of amantadine for the prevention of Hong Kong influenza. Bull. World Health. Organ. 42, 423–427.
Oker-Blom, N., Hovi, T., Leinikki, P., Palosuo, T., Pettersson, R., Suni, J., 1970. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. Br. Med. J. 3, 676–678.
Pettersson, R.F., Hellstrom, P.E., Penttinen, K., Pyhala, R., Tokola, O., Vartio, T., Visakorpi, R., 1980. Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients. J. Infect. Dis. 142, 377–383.
Quarles, J.M., Couch, R.B., Cate, T.R., Goswick, C.B., 1981. Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza. Antiviral. Res. 1, 149–155.
Stilianakis, N.I., Perelson, A.S., Hayden, F.G., 1998. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J. Infect. Dis. 177(4), 863–873.
Webster, R.G., 2004. Wet markets—a continuing source of severe acute respiratory syndrome and influenza?. Lancet 363(9404), 234–236.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hsu, SB., Hsieh, YH. On the Role of Asymptomatic Infection in Transmission Dynamics of Infectious Diseases. Bull. Math. Biol. 70, 134–155 (2008). https://doi.org/10.1007/s11538-007-9245-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-007-9245-6